Reduced expression of aphidicolin-induced common fragile sites in peripheral lymphocyte chromosomes of patients with B-cell chronic lymphocytic leukemia
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 39 (1) , 99-102
- https://doi.org/10.1016/0165-4608(89)90235-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Chromosome abnormalities in chronic lymphocytic leukemia revealed by cytochalasin B and Epstein-Barr virusCancer Genetics and Cytogenetics, 1987
- Single-strand breaks or alkali-sensitive sites in the DNA of human myeloma plasma cells and chronic lymphocytic leukemia lymphocytesCanadian Journal of Biochemistry and Cell Biology, 1985
- DNA polymerase ? inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomesHuman Genetics, 1984
- Clinical significance of cytogenetic findings in untreated patients with B-cell chronic lymphocytic leukemiaCancer Genetics and Cytogenetics, 1984
- Arrest of Chain Growth of Replicon‐Sized Intermediates by Aphidicolin During Rat Fibroblast Cell Chromosome ReplicationEuropean Journal of Biochemistry, 1982
- Chromosome changes in human chronic lymphocytic leukemiaCancer Genetics and Cytogenetics, 1981
- New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase αCell, 1981
- Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulationBlood, 1980
- Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-αNature, 1978